Results 61 to 70 of about 2,302 (210)

Influence of asilsartan medoxomile on arterial hypertension variability in patients with arterial hypertension and chronic obstructive pulmonary disease

Лечащий Врач, 2021
We studied hypotensive effects, as well as short-term, daily and long-term variability of arterial pressure against the background of treatment with angiotensin-transforming ferment inhibitor and angiotensin-ferment blockers II in patients with arterial ...
N. Yu. Grigorieva, M. E. Koroleva
doaj  

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton, Michael R. Gionfriddo, Gail B. Rattinger, Yuan Fang, Mia E. Lussier   +4 more
wiley   +1 more source

Histological Study on the Possible Protective Effect of Probiotics versus Fosinopril in a Rat Model of Myocardial Infarction

The Egyptian Journal of Histology
Introduction: Myocardial infarction (MI) is major health issue implicated in high rates of mortality globally. Fosinopril is an angiotensin converting enzyme inhibitor (ACE-I) which is linked to ameliorating cardiovascular disorders.
seham AbdElhamid Mohamed elkalawy, Dina Mohamed Radwan, Shimaa Mohsen Emam, Manal Ali Abdel Mohsen   +3 more
doaj   +1 more source

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES

Кубанский научный медицинский вестник, 2017
Aim. The article discusses the evaluation of the effect of 3-month therapy of angiotensin-converting enzyme fosinopril and angiotensin II receptor antagonists valsartan on the clinical manifestations of CHF, hemodynamics and morphofunctional parameters ...
Z. V. BITAROVA, O. V. REMIZOV, Z. T. ASTAKHOVА   +2 more
doaj   +1 more source

Association between prescription drugs and all‐cause mortality risk in the UK population

Aging Cell, Volume 23, Issue 12, December 2024.
The UK Biobank has collected data on prescription medications and mortality for over 500,000 participants aged 40–70 years. We analyzed the effects of the top 406 prescribed medications on overall mortality rates in the general population. Most drugs were linked to a shortened lifespan, likely due to the life‐limiting nature of the diseases they are ...
Jonas Morin, Yves Rolland, Heike A. Bischoff‐Ferrari, Alejandro Ocampo, Kevin Perez   +4 more
wiley   +1 more source

Effects of fosinopril treatment on blood pressure during physical and mental stress test in essential hypertension

, 1999
In this study the effects of once daily administration of 10 mg fosinopril on blood pressure response to mental and physical stress were evaluated in mild to moderate essential hypertension.

core   +1 more source

On the effect of fosinopril in patients with diabetic neuropathy

, 2003
Objective: Angiotensin converting enzyme (ACE) inhibitors have been shown to delay the progression of microvascular complications of diabetes mellitus. The effect of fosinopril on diabetic neuropathy over six months was investigated.
Vural Ö., Gürgen N.A., Özer H.T.E., Altun B.U.   +3 more
core   +1 more source

Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence

Journal of Experimental Orthopaedics, Volume 11, Issue 4, October 2024.
Abstract Purpose Despite advances in surgical techniques and rehabilitation protocols, arthrofibrosis following total knee arthroplasty (TKA) still has poor outcomes. In the last decade, attention has been focused on the pathogenesis and cascade of events leading to the development of fibrosis.
Giuseppe Anzillotti, Andreas H. Gomoll, Pietro Conte, Alberto Bulgarelli, Paolo Queirazza, Maurilio Marcacci, Elizaveta Kon, Berardo Di Matteo   +7 more
wiley   +1 more source

Possibilities of using Fosinopril, an angiotensinconverting enzyme inhibitor, combined with Diltiazem, a non-dihydropyridine calcium antagonist, as first-line therapy in the treatment of arterial hypertension (clinical case)

Медицинский совет, 2019
The article exemplified the successful experience of using combination therapy consisting of fosinopril, an angiotensin-converting enzyme inhibitor, and diltiazem, a non-dihydropyridine calcium antagonist, in a patient with a history of arterial ...
O. D. Ostroumova, I. V. Goloborodova
doaj   +1 more source

FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION

, 2010
The multidrug-resistance associated protein 2 (MRP2) is a membrane-bound transporter responsible for the efflux of a variety of drugs and endogenous compounds.
Green, Benjamin
core